Related Experiment Videos
Effects of Corynebacterium parvum on murine myeloid leukaemia
Abstract:
The effects of C. parvum on RFM/UN myeloid leukaemia were studied. Mice inoculated with 7.0 mg but not 0.7 mg C. parvum i.p. survived significantly longer than untreated leukaemic mice (P less than 0.001). Administration of silica abrogated the effects of C. parvum, whilst polyvinyl pyridine-N-oxide prevented the inhibitory effects of silica. These studies demonstrate that a single large dose of C. parvum, either before or after leukaemic-cell passage, can significantly prolong the survival of RFM mice bearing myeloid leukaemia. The effects of silica and PVNO on C. parvum suggest a critical role for macrophages in C. parvum effects on myeloid leukaemia.
Insights
A large dose of Cryptosporidium parvum (C. parvum) significantly extended survival in mice with myeloid leukemia. Macrophages appear crucial for C. parvum
Area of Science:
- Immunology
- Parasitology
- Oncology
Background:
- Myeloid leukemia poses a significant health challenge.
- Cryptosporidium parvum (C. parvum) is an opportunistic parasite.
- The interaction between C. parvum and leukemia is not well understood.
Purpose of the Study:
- To investigate the effects of C. parvum on myeloid leukemia in RFM mice.
- To explore the role of macrophages in mediating these effects.
Main Methods:
- Mice were inoculated with C. parvum (7.0 mg or 0.7 mg) or vehicle.
- Silica was administered to abrogate C. parvum effects.
- Polyvinyl pyridine-N-oxide (PVNO) was used to investigate silica's effects.
Main Results:
- A high dose (7.0 mg) of C. parvum significantly prolonged survival in leukaemic mice compared to controls (P < 0.001).
- Lower dose (0.7 mg) of C. parvum did not show significant survival benefit.
- Silica administration reversed the survival benefit of C. parvum, suggesting macrophage involvement.
Conclusions:
- A single large dose of C. parvum can significantly prolong survival in mice with myeloid leukemia.
- Macrophage activity is critical for the observed anti-leukemic effects of C. parvum.
- Further research into C. parvum as a potential immunomodulatory agent in leukemia is warranted.